Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SNDX

Syndax Pharmaceuticals Inc

May 29 • 04:00PM ET

19.59

-0.16 -0.81 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RCUS TNGX CGON KYMR NUVL RYTM BMRN INCY KRYS AXSM

| Held by: VTI XBI IWM VXF IWO IBB VTWO SCHA VHT FYC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.80	Insider Own	9.24%	Shs Outstand	88.54M	Perf Week	-0.91%
Market Cap	1.74B	Forward P/E	-	EPS next Y	-0.59	Insider Trans	-0.37%	Shs Float	80.42M	Perf Month	-5.04%
Enterprise Value	1.73B	PEG	-	EPS next Q	-0.48	Inst Own	106.02%	Short Float	27.00%	Perf Quarter	-9.77%
Income	-243.25M	P/S	7.98	EPS this Y	45.70%	Inst Trans	-1.44%	Short Ratio	13.92	Perf Half Y	0.72%
Sales	217.42M	P/B	41.67	EPS next Y	67.11%	ROA	-43.70%	Short Interest	21.71M	Perf YTD	-6.76%
Book/sh	0.47	P/C	4.93	EPS next 5Y	-	ROE	-189.53%	52W High	25.59 -23.45%	Perf Year	84.46%
Cash/sh	3.97	P/FCF	-	EPS past 3/5Y	-10.26% -12.05%	ROIC	-62.94%	52W Low	8.59 128.19%	Perf 3Y	-2.05%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 157.68%	Gross Margin	95.99%	Volatility	3.44% 4.90%	Perf 5Y	6.64%
Dividend TTM	-	EV/Sales	7.95	EPS Y/Y TTM	27.68%	Oper. Margin	-102.81%	ATR (14)	0.92	Perf 10Y	41.04%
Dividend Ex-Date	-	Quick Ratio	5.06	Sales Y/Y TTM	397.28%	Profit Margin	-111.88%	RSI (14)	40.39	Recom	1.08
Dividend Gr. 3/5Y	- -	Current Ratio	5.47	EPS Q/Q	50.89%	SMA20	-2.72%	Beta	0.39	Target Price	39.25
Payout	-	Debt/Eq	8.30	Sales Q/Q	223.64%	SMA50	-11.43%	Rel Volume	0.55	Prev Close	19.75
Employees	298	LT Debt/Eq	8.29	Earnings	Apr 30 AMC	SMA200	1.39%	Avg Volume	1.56M	Price	19.59
IPO	Mar 03, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	21.03% -7.02%	Trades		Volume	860,288	Change	-0.81%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)